Article

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

2021-12-09

Abstract excerpt

The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may compromise vaccine effectiveness and the ability of antibodies triggered by previous infection to protect against re-infection (1). Here we investigated whether Omicron escapes antibody neutralization in South Africans, either previously SARS-CoV-2 infected or uninfected, who were vaccinated with Pfizer BNT162b2. We also invest...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9dcd008f-984e-553a-afad-c85fdc5b7aab
DOI: 10.1101/2021.12.08.21267417

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infectionDOI 10.1101/2021.12.08.21267417Read

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.Semantic proximity Read

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.Semantic proximity Read

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variantsSemantic proximity Read

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralizationSemantic proximity Read

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escapeSemantic proximity Read

Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunitiesSemantic proximity Read

Immunogenicity of Convalescent and Vaccinated Sera Against Clinical Isolates of Ancestral SARS-CoV-2, Beta, Delta, and Omicron VariantsSemantic proximity Read

Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human seraSemantic proximity Read

SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3<sup>rd</sup> mRNA Vaccine DoseSemantic proximity Read

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity Read

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read